Transactions
Affichage de - 153 éléments sur 968
-
US$50m
Cardiol Therapeutics, Inc.
Lead Left Bookrunner (Follow-On Offering)
-
N/a
InvoX
Financial Adviser (Buy side)
-
$135m
ObsEva
Committed debt facility
-
A$35m
ImpediMed
Joint Lead Manager (Placement)
-
US$70m
Lucid Diagnostics Inc.
Joint Bookrunner (IPO)
-
US$143m
Paragon 28, Inc.
Lead Manager (IPO)
-
N/a
Ares Management
Financial Advisor (Buy side)
-
n/A
PharmaCann
Financial Advisor (Buy side)
-
US$4b
Babylon Holdings Limited
Financial/Capital Markets Advisor (SPAC)
